[Cancer Management and Research] Researchers present a comparison study on the sensitivity and accuracy of 3 types of imaging studies — contrast-enhanced ultrasound, MRI, and computed tomography — in diagnosing and classifying pancreatic cystic neoplasms.
A review of techniques oncology nurses can use to help themselves cope with their feelings as they navigate through the effects of the COVID-19 pandemic on their practice, their patients, and themselves.
A reflection on survivorship issues and up-to-date reports on current trends in treatment management.
[Oncotargets and Therapy] Some data support use of immunotherapy for breast cancer; however, as a monotherapy, only a small percentage of patients will benefit from the treatment. This review discusses the current status of efforts to improve immunotherapy through combinations with other therapies.
A review of our most popular articles from our 10 years of publication.
Expertise in the use of nonpharmacologic pain management techniques and therapies allow masters-prepared social workers to be an integral member of a multidisciplinary cancer care team.
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
As part of our 10-year anniversary celebration, this article presents a retrospective on how the changes in oncology have influenced the growth of the oncology nurse profession.
[Cancer Management and Research] This review focuses on how identification of molecular alterations and risk stratification would contribute to individualized-therapeutic decision-making in AML.
ILROG has issued guidelines on alternative radiation treatment methods to combat limited treatment resources for cancer patients during the COVID-19 pandemic.
The multicenter, randomized REACH2 trial demonstrated that ruxolitinib is efficacious and safe for patients with aGVHD after allogeneic stem cell transplantation.
IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.
Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.
ONA speaks with Laura Fennimore, president of the Oncology Nursing Society, about how the oncology nursing field is evolving, what will influence oncology nursing practice, and how a pandemic could affect cancer care.
[Journal of Hepatocellular Carcinoma] In this review, the authors discuss the use of imaging techniques and radiological biomarkers to monitor treatment response in patients with advanced HCC undergoing antiangiogenic therapy, a key to decisions on whether to continue treatment or initiate second-line therapy.